Search

Home > News & Events > Current News

Current News

Current SATVI news

August 2019 Latest Research Published Results MTBVAC vaccine candidate offer hope for control of tuberculosis in infants
Tue, 13 Aug 2019 - 09:30

SATVI researchers have just published an article titled: "Live-attenuated Mycobacterium tuberculosis vaccine MTBVAC versus BCG in adults and neonates: a randomised controlled, double-blind dose-escalation trial" appearing in the Lancet Respiratory Medicine journal. 

August 2019 Research: Potential population level impact on tuberculosis incidence of using an mRNA expression signature correlate-of-risk test to target tuberculosis preventive therapy
Fri, 02 Aug 2019 - 14:00
South African Tuberculosis Vaccine Initiative researchers Professors Mark Hatherill, Tom Scriba and Doctor Adam Penn-Nicholson have co-authored a research paper titled "Potential population level impact on tuberculosis incidence of using an mRNA expression signature correlate-of-risk test to target tuberculosis preventive therapy" appearing in the Scientific Reports journal.
July 2019 Research: Multinomial modelling of TB/HIV co-infection yields a robust predictive signature and generates hypotheses about the HIV+TB+ disease state.
Fri, 26 Jul 2019 - 15:30

SATVI researcher Professor Tom Scriba has co-authored a research paper titled "Multinomial modelling of TB/HIV co-infection yields a robust predictive signature and generates hypotheses about the HIV+TB+ disease state" appearing in the PLoS One journal.

July 2019 Detection of Tuberculosis recurrence, diagnosis and treatment response by a blood transcriptomic risk signature in HIV-Infected Persons on Antiretroviral Therapy.
Fri, 26 Jul 2019 - 15:15

SATVI researchers Professors Mark Hatherill, Tom Scriba, Doctors Darboe, Penn-Nicholson, Mbandi, Nicole Bilek, SImba Mabwe have authored a research paper titled "Detection of Tuberculosis recurrence, diagnosis and treatment response by a blood transcriptomic risk signature in HIV-infected persons on Antiretroviral Therapy" appearing in the Frontiers in Microbiology journal.

July 2019 Research Performance of host blood transcriptomic signatures for diagnosing and predicting progression to tuberculosis disease in HIV-negative adults and adolescents: a systematic review protocol.
Fri, 26 Jul 2019 - 15:00

SATVI researchers Professors Mark Hatherill, Tom Scriba, Humphrey Mulenga and Doctors Eric Bunyase, Mbandi, Mendelsohn, Kagina and Penn-Nicholson have authored a research paper titled: "Performance of host blood transcriptomic signatures for diagnosing and predicting progression to tuberculosis disease in HIV-negative adults and adolescents: a systematic review protocol" appearing in the British Medical Journal.

June 2019 Research Temporal trends in the prevalence of Mycobacterium tuberculosis infection in South African adolescents.
Fri, 26 Jul 2019 - 14:30

SATVI researchers Profesors Mark Hatherill, Tom Scriba, Doctors Bunyasi, Geldenhuys, Mulenga, Shenje, Luabeya, Tameris, Nemes, Rozot have authored a research paper titled "Temporal trends in the prevalence of Mycobacterium tuberculosis infection in South African adolescents" appearing in the International Journal of Tuberculosis and Lung Disease.

June 2019 Research Paediatric tuberculosis transmission outside the household: challenging historical paradigms to inform future public health strategies.
Fri, 26 Jul 2019 - 13:30

Professor Mark Hatherill has co-authored a article titled: "Paediatric tuberculosis transmission outside the household: challenging historical paradigms to inform future public health strategies" appearing in the Lancet Respiratory Medicine journal.

19 June 2019 Latest Keystone Symposium
Wed, 19 Jun 2019 - 13:00

Cheleka Mpande, SATVI researcher features in the latest online Keystone Symposium in which she explains the paper titled “Functional, antigen-specific stem cell memory (TSCM) CD4+ T cells are induced by human M.tuberculosis infection”

31 May 2019 Latest Research Moving tuberculosis vaccines from theory to practice
Fri, 31 May 2019 - 14:45

Professor Tom Scriba has co-authored a paper titled: "Moving tuberculosis vaccines from theory to practice" appearing in the Nature Reviews Immunology Journal.  

26 April 2019 New Vacancies added
Fri, 26 Apr 2019 - 13:30

SATVI invites applications to several positions at its Worcester field site office.  

 

16 April 2019 Latest Research: Discovery and validation of a prognostic proteomic signature for tuberculosis progression: A prospective cohort study
Wed, 17 Apr 2019 - 08:15

SATVI authors Drs. Adam Penn-Nicholson, Stanley Kimbung Mbandi, Michelle Fisher, Professors Mark Hatherill and Tom Scriba have co-authored a paper titled "Discovery and validation of a prognostic proteomic signature for tuberculosis progression: A prospective cohort study" appearing in the Plos Medicine journal. 

14 April 2019 SATVI wins Social Responsiveness Award
Sun, 14 Apr 2019 - 19:45

University of Cape Vice Chancellor, Professor Mamokgethi Phakeng announced the South African Tuberculosis Vaccine Initiative (SATVI) as the winner of the 2018 Vice Chancellor Social Responsiveness Award during the April 2019 Health Faculty Sciences graduation. 

Pages